Esperion rises as partner launches cholesterol drug in Japan
ReutersNov 21, 2025 5:06 PM
Shares of drug developer Esperion ESPR.O rise 7% to $3.15 during afternoon trading
Co says it will receive a $90 million payment after its Japanese partner, Otsuka Pharmaceutical, launched cholesterol-lowering drug Nexletol in Japan.
Otsuka received national approval to sell Nexletol for patients with high cholesterol and certain inherited cholesterol disorders, ESPR says
ESPR eligible for additional milestones and 15%-30% royalties on Japan sales
Japan is third-largest market for cardiovascular prevention, ESPR says
Including session's move, shares up ~44% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey
Related Articles
Elon Musk’s SpaceX Poised for Record-Breaking IPO: How Can Retail Investors Get In on the Action of Starlink Stock?
TradingKey - Elon Musk's rocket manufacturer SpaceX is expected to launch an IPO in 2026, with a target IPO valuation projected to reach $1.5 trillion. However, prior to its listing, the stock can only be traded in the private market, characterized by low information transparency and high capital baTradingKey
14 hours ago
Musk’s Next Ambition: Building a Space-Based AI Data Center
TradingKey - Musk has long resisted the idea of taking SpaceX public. After the Tesla take-private drama and the resulting SEC penalties (which cost him the chairmanship), he’s been wary of public market entanglements. But something’s changed—and fast.TradingKey
Thu, Dec 18
Japan Central Bank Rate Hike To Three-Decade High Imminent, How Will The Market Go? Which Assets Most Affected?
As global monetary policy divergence enters a critical phase, the Bank of Japan (BoJ) is anticipated to raise its benchmark interest rate at the monetary policy meeting on December 19, 2025, by 25 basis points to 0.75% , marking its highest level in nearly 30 years.TradingKey
Thu, Dec 18
Gold Price Steady Climb and the Sudden Surge of Silver and Copper: Will Their Bull Run Extend Into 2026?
Dow Jones Market Data shows this marks the first time since 1980all three metals—gold, silver, and copper—simultaneously refreshed their all-time highs in the same year. Will this rally extend into 2026?TradingKey
Wed, Dec 10
Tradingkey
